Short description
ReVision Therapeutics, a biopharmaceutical company, develops drugs for the treatment of age-related macular degeneration diseases.
Description
ReVision Therapeutics, Inc. develops drugs for the treatment of age-related macular degeneration diseases. Its product includes Fenretinide, an oral medication that reduces the accumulation of A2E in the retina, and slows down the growth of atrophic lesions, which precedes vision loss. The company was founded in 2010 and is based in San Diego, California.
Total funding
$$121212
Sign in for full access
Location
San Diego, California, United States, North America
Founded on
January 1, 2010
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$34056 - 789030
Sign in for full access